Lenalidomide in relapsed refractory myeloma patients: impact of previous response to bortezomib and thalidomide on treatment efficacy. Results of a medical need program in Belgium. 01/01/2011 Lees meer
25th General Meeting of the Belgian Hematological Society, Oostende: lid organizing and scientific board, chairman ‘state of the art lectures’, business meeting: voorstelling financiële status. 29/01/2010 Lees meer
Belgian Hematological Society 29 en 30.01.10, te Oostende. – Is there an increased incidence of plasmablastic transformation in multiple myeloma after treatment with Imids and bortezomib? 29/01/2010 Lees meer
Posterabstract Belgian Hematological Society 29 en 30.01.10, te Oostende.Mixed phenotype acute leukaemia with MLL/AF4 rearrangement: A case report with sudden lineage switch. 29/01/2010 Lees meer
The Belgian 2010 consensus recommendations for the treatment of multiple myeloma. 01/01/2010 Lees meer
